Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity.

Abstract

Telmisartan improves both hemodynamic and metabolic abnormalities found in hypertensive patients with obesity. The additional benefits may be partly due to visceral fat remodeling.